newsfilter
← Latest News
GlobeNewswire·

Kailera Therapeutics Announces Pricing of Initial Public Offering

WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (NASDAQ:KLRA) (Kailera), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced